enbucrilate has been researched along with thymopentin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, W; Jiang, X; Zhang, ZR | 1 |
| Hong, Y; Jin, X; Liu, Q; Lu, S; Ping, Q; Rao, Y; Shen, Y; Webster, TJ; Xu, B; Xu, Y | 1 |
2 other study(ies) available for enbucrilate and thymopentin
| Article | Year |
|---|---|
Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin.
Topics: Administration, Oral; Animals; Biological Availability; Cell Proliferation; Cells, Cultured; Chemical Precipitation; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Enbucrilate; Feasibility Studies; Female; Flow Cytometry; Immunologic Factors; Mice; Mice, Inbred BALB C; Models, Chemical; Nanoparticles; Particle Size; Rats; Rats, Wistar; Solubility; Surface Properties; T-Lymphocytes; Technology, Pharmaceutical; Thymopentin | 2008 |
Preparation, intestinal segment stability, and mucoadhesion properties of novel thymopentin-loaded chitosan derivatives coated with poly (n-butyl) cyanoacrylate nanoparticles.
Topics: Adhesiveness; Animals; Biocompatible Materials; Chitosan; Drug Carriers; Drug Liberation; Enbucrilate; Intestines; Mucus; Nanoparticles; Particle Size; Rats, Sprague-Dawley; Static Electricity; Thymopentin; Time Factors | 2019 |